Neurodegeneration

Funding Resources
Funding Overview
Funding Strategy
Funding Opportunities
Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News

Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Features
RFI: Soliciting Input on Current Needs in Emergency Medicine Research New Public Access Policy for NIH Grantees Electronic Submission Updates Register with Grants.gov and NIH eRA Commons NIH eSubmission Tips for Investigators (pdf file, 56 K) NIH Model Sharing Requirement for Investigators NIH Fiscal Policy for Grant Awards in FY2008

Scientific Area of Research

Neuronal cell death, how protein aggregation damages neurons, and the interaction of genes and the environment in the etiology of neurodegenerative diseases.

Current Funding Announcements

*Note: The Electronic Submission process for grant applications has begun at NIH. Register with Grants.gov and NIH eRA Commons so that you may start preparing for this transtion

Funding announcement information is updated daily throughout the NINDS website. If individual funding announcements are not listed below, it means that there are no current solicitations available for this particular Program Area. Please continue to check this web page for the latest RFA's, PA's, RFP's and Notices related to this Program Area.

Requests for Application (RFA)
(Sorted by Application Receipt Date)

Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34) [Summary]
Application Receipt Date: November 25, 2008 Letter of Intent Date: October 24, 2008
Announcement Number: RFA-DK-08-003
Funding Contact: Margaret Sutherland, Ph.D. Program Area: Neurodegeneration

Translation of Common Disease Genetics into Clinical Applications (R21) [Summary]
Application Receipt Date: November 25, 2008 Letter of Intent Date: October 24, 2008
Announcement Number: RFA-DK-08-004
Funding Contact: Margaret Sutherland, Ph.D. Program Area: Neurodegeneration

Program Announcements (PA)
(Sorted by Application Receipt Date)

Developmental Pharmacology (R01) [Summary]
Application Receipt Date: September 22, 2008 Letter of Intent Date: August 22, 2008
Announcement Number: PAR-07-416
Funding Contact: Margaret Sutherland, Ph.D. Program Area: Neurodegeneration

Morris K. Udall Parkinson’s Disease Centers of Excellence (P50) [Summary]
Application Receipt Date: September 25, 2008
Announcement Number: PAR-06-058
Funding Contact: Diane DiEuliis, Ph.D. Program Area: Neurodegeneration

Research on the Cognitive Sequelae of Parkinson's Disease (R01) [Summary]
Application Receipt Date: October 5, 2008
Announcement Number: PA-07-198
Funding Contact: Diane DiEuliis, Ph.D. Program Area: Neurodegeneration

Grants for Alzheimer's Disease Drug Discovery (R21) [Summary]
Application Receipt Date: October 16, 2008
Announcement Number: PAS-06-261
Funding Contact: Diane DiEuliis, Ph.D. Program Area: Neurodegeneration

Research on the Cognitive Sequelae of Parkinson's Disease (R03) [Summary]
Application Receipt Date: October 16, 2008
Announcement Number: PA-06-194
Funding Contact: Debra Babcock, MD., Ph.D. Program Area: Neurodegeneration, Systems and Cognitive Neuroscience

Research on the Cognitive Sequelae of Parkinson's Disease (R21) [Summary]
Application Receipt Date: October 16, 2008
Announcement Number: PA-06-195
Funding Contact: Debra Babcock, MD., Ph.D. Program Area: Neurodegeneration, Systems and Cognitive Neuroscience

Academic Research Enhancement Award (R15) [Summary]
Application Receipt Date: October 25, 2008
Announcement Number: PA-06-042
Funding Contact: Randall Stewart, Ph.D. Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

Research Supplements to Promote Diversity in Health-Related Research [Summary]
Application Receipt Date: November 15, 2008
Announcement Number: PA-08-190
Funding Contact: Michelle Jones-London, Ph.D. Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers [Summary]
Application Receipt Date: November 15, 2008
Announcement Number: PA-08-191
Funding Contact: Michelle Jones-London, Ph.D. Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

PHS 2008-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) [Summary]
Application Receipt Date: December 5, 2008
Announcement Number: PA-08-051
Funding Contact: NINDS Funding Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience, Training and Career Development

PHS 2008-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) [Summary]
Application Receipt Date: December 5, 2008
Announcement Number: PA-08-050
Funding Contact: NINDS Funding Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

Notices (NOT)
(Sorted by Release Date)

NIH/AHRQ Confirms Plans to Transition the G7, G8, G11, G13, G20, S11, S21 and S22 to Electronic Applications and Announces Delay in Transition of K, F, T and Complex Grant Programs [Summary]
Release Date: January 19, 2007
Announcement Number: NOT-OD-07-038
Funding Contact: NINDS Funding Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

Policy Revision of the National Institute of Neurological Disorders and Stroke (NINDS) for Competing Program Project (P01) and Unsolicited Center Grant (P50) Applications [Summary]
Release Date: May 15, 2007
Announcement Number: NOT-NS-07-010
Funding Contact: Robert Finkelstein, Ph.D. Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience

Amendment to NOT-NS-07-010: Policy Revision of the National Institute of Neurological Disorders and Stroke (NINDS) for Competing Program Project (P01/P50) Grant Applications [Summary]
Release Date: February 6, 2008
Announcement Number: NOT-NS-08-010
Funding Contact: Emmeline Edwards, Ph.D. Program Area: Neural Environment, Neurodegeneration, Neurogenetics, Repair and Plasticity, Technology Development, Training and Career Development, Office of Minority Health and Research, Channels, Synapses and Neural Circuits, Clinical Trials, Systems and Cognitive Neuroscience, Training and Career Development

View Archived Announcements

Additional Information

Mission:
The Neurodegeneration cluster portfolio consists of research on the adult onset neurodegenerative diseases of all types, broadly focusing on the pathogenesis, treatment and prevention. Necessarily included is research on the normal structure and function of the neural systems to more readily identify intervention strategies. The role of the programmatic team is to develop, implement and manage these research programs and to promote the translation of research findings into clinical practice.